Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state

  1. Yarden Katz
  2. Feifei Li
  3. Nicole J Lambert
  4. Ethan S Sokol
  5. Wai Leong Tam
  6. Albert W Cheng
  7. Edoardo M Airoldi
  8. Christopher J Lengner
  9. Piyush B Gupta
  10. Zhengquan Yu
  11. Rudolf Jaenisch
  12. Christopher B Burge  Is a corresponding author
  1. Massachusetts Institute of Technology, United States
  2. China Agricultural University, China
  3. Whitehead Institute for Biomedical Research, United States
  4. Harvard University, United States
  5. University of Pennsylvania, United States

Abstract

The conserved Musashi (Msi) family of RNA binding proteins are expressed in stem/progenitor and cancer cells, but generally absent from differentiated cells, consistent with a role in cell state regulation. We found that Msi genes are rarely mutated but frequently overexpressed in human cancers, and are associated with an epithelial-luminal cell state. Using ribosome profiling and RNA-seq analysis of genetic mouse models in neuronal and mammary cell types, we found that Msis regulate translation of genes implicated in epithelial cell biology and epithelial-to-mesenchymal transition (EMT) and promote an epithelial splicing pattern. Overexpression of Msi proteins inhibited translation of genes required for EMT, including Jagged1, and repressed EMT in cell culture and in mammary gland in vivo, while knockdown in epithelial cancer cells promoted loss of epithelial identity. Our results show that mammalian Msi proteins contribute to an epithelial gene expression program in neural and mammary cell types.

Article and author information

Author details

  1. Yarden Katz

    Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    No competing interests declared.
  2. Feifei Li

    China Agricultural University, Beijing, China
    Competing interests
    No competing interests declared.
  3. Nicole J Lambert

    Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    No competing interests declared.
  4. Ethan S Sokol

    Whitehead Institute for Biomedical Research, Cambridge, United States
    Competing interests
    No competing interests declared.
  5. Wai Leong Tam

    Whitehead Institute for Biomedical Research, Cambridge, United States
    Competing interests
    No competing interests declared.
  6. Albert W Cheng

    Whitehead Institute for Biomedical Research, Cambridge, United States
    Competing interests
    No competing interests declared.
  7. Edoardo M Airoldi

    Harvard University, Cambridge, United States
    Competing interests
    Edoardo M Airoldi, Reviewing Editor, eLife.
  8. Christopher J Lengner

    University of Pennsylvania, Philadelphia, United States
    Competing interests
    No competing interests declared.
  9. Piyush B Gupta

    Whitehead Institute for Biomedical Research, Cambridge, United States
    Competing interests
    No competing interests declared.
  10. Zhengquan Yu

    China Agricultural University, Beijing, China
    Competing interests
    No competing interests declared.
  11. Rudolf Jaenisch

    Whitehead Institute for Biomedical Research, Cambridge, United States
    Competing interests
    No competing interests declared.
  12. Christopher B Burge

    Massachusetts Institute of Technology, Cambridge, United States
    For correspondence
    cburge@mit.edu
    Competing interests
    No competing interests declared.

Ethics

Animal experimentation: Mice of the 129SvJae strain were used, and the K14-rTTA strain were obtained from JAX (stock number: 007678). Animal care was performed in accordance with institutional guidelines and approved by the Committee on Animal Care, Department of Comparative Medicine, Massachusetts Institute of Technology, under animal protocol 1013-088-16

Copyright

© 2014, Katz et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,047
    views
  • 654
    downloads
  • 80
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yarden Katz
  2. Feifei Li
  3. Nicole J Lambert
  4. Ethan S Sokol
  5. Wai Leong Tam
  6. Albert W Cheng
  7. Edoardo M Airoldi
  8. Christopher J Lengner
  9. Piyush B Gupta
  10. Zhengquan Yu
  11. Rudolf Jaenisch
  12. Christopher B Burge
(2014)
Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state
eLife 3:e03915.
https://doi.org/10.7554/eLife.03915

Share this article

https://doi.org/10.7554/eLife.03915

Further reading

    1. Cancer Biology
    2. Chromosomes and Gene Expression
    Ashley L Cook, Surojit Sur ... Nicolas Wyhs
    Research Article

    Despite exciting developments in cancer immunotherapy, its broad application is limited by the paucity of targetable antigens on the tumor cell surface. As an intrinsic cellular pathway, nonsense-mediated decay (NMD) conceals neoantigens through the destruction of the RNA products from genes harboring truncating mutations. We developed and conducted a high-throughput screen, based on the ratiometric analysis of transcripts, to identify critical mediators of NMD in human cells. This screen implicated disruption of kinase SMG1’s phosphorylation of UPF1 as a potential disruptor of NMD. This led us to design a novel SMG1 inhibitor, KVS0001, that elevates the expression of transcripts and proteins resulting from human and murine truncating mutations in vitro and murine cells in vivo. Most importantly, KVS0001 concomitantly increased the presentation of immune-targetable human leukocyte antigens (HLA) class I-associated peptides from NMD-downregulated proteins on the surface of human cancer cells. KVS0001 provides new opportunities for studying NMD and the diseases in which NMD plays a role, including cancer and inherited diseases.

    1. Cancer Biology
    Ke Ning, Yuanyuan Xie ... Ling Yu
    Research Article

    For traditional laboratory microscopy observation, the multi-dimensional, real-time, in situ observation of three-dimensional (3D) tumor spheroids has always been the pain point in cell spheroid observation. In this study, we designed a side-view observation petri dish/device that reflects light, enabling in situ observation of the 3D morphology of cell spheroids using conventional inverted laboratory microscopes. We used a 3D-printed handle and frame to support a first-surface mirror, positioning the device within a cell culture petri dish to image cell spheroid samples. The imaging conditions, such as the distance between the mirror and the 3D spheroids, the light source, and the impact of the culture medium, were systematically studied to validate the in situ side-view observation. The results proved that placing the surface mirror adjacent to the spheroids enables non-destructive in situ real-time tracking of tumor spheroid formation, migration, and fusion dynamics. The correlation between spheroid thickness and dark core appearance under light microscopy and the therapeutic effects of chemotherapy doxorubicin and natural killer cells on spheroids’ 3D structure was investigated.